Literature DB >> 20395340

Pathophysiology of myocardial injury and remodeling: implications for molecular imaging.

Jennifer A Dixon1, Francis G Spinale.   

Abstract

Despite advances in reperfusion therapy, acute coronary syndromes can still result in myocardial injury and subsequent myocardial infarction (MI). Molecular, cellular, and interstitial events antecedent to the acute MI culminate in deleterious changes in the size, shape, and function of the left ventricle (LV), collectively termed LV remodeling. Three distinct anatomic and physiologic LV regions can be described after MI: the infarct, border zone, and remote regions. Given the complexity of post-MI remodeling, imaging modalities must be equally diverse to elucidate this process. The focus of this review will first be on cardiovascular MRI of the anatomic and pathophysiologic LV regions of greatest interest with regard to the natural history of the post-MI remodeling process. This review will then examine imaging modalities that provide translational and molecular insight into burgeoning treatment fields for the attenuation of post-MI remodeling, such as cardiac restraint devices and stem cell therapy.

Entities:  

Mesh:

Year:  2010        PMID: 20395340      PMCID: PMC3045843          DOI: 10.2967/jnumed.109.068213

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  38 in total

1.  Prolyl hydroxylase and collagen metabolism after experimental mycardial infarction.

Authors:  J T Judd; B C Wexler
Journal:  Am J Physiol       Date:  1975-01

2.  Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells.

Authors:  Jonathan M Hill; Alexander J Dick; Venkatesh K Raman; Richard B Thompson; Zu-Xi Yu; K Allison Hinds; Breno S S Pessanha; Michael A Guttman; Timothy R Varney; Bradley J Martin; Cynthia E Dunbar; Elliot R McVeigh; Robert J Lederman
Journal:  Circulation       Date:  2003-08-11       Impact factor: 29.690

3.  Vascular remodeling during healing after myocardial infarction in the dog model: effects of reperfusion, amlodipine and enalapril.

Authors:  Bodh I Jugdutt; Vijayan Menon; Dinender Kumar; Halliday Idikio
Journal:  J Am Coll Cardiol       Date:  2002-05-01       Impact factor: 24.094

4.  In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction.

Authors:  Dara L Kraitchman; Alan W Heldman; Ergin Atalar; Luciano C Amado; Bradley J Martin; Mark F Pittenger; Joshua M Hare; Jeff W M Bulte
Journal:  Circulation       Date:  2003-05-05       Impact factor: 29.690

5.  Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction.

Authors:  David F Meoli; Mehran M Sadeghi; Svetlana Krassilnikova; Brian N Bourke; Frank J Giordano; Donald P Dione; Haili Su; D Scott Edwards; Shuang Liu; Thomas D Harris; Joseph A Madri; Barry L Zaret; Albert J Sinusas
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

6.  Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling.

Authors:  Eric M Wilson; Sina L Moainie; Julia M Baskin; Abigail S Lowry; Anne M Deschamps; Rupak Mukherjee; T Sloane Guy; Martin G St John-Sutton; Joseph H Gorman; L Henry Edmunds; Robert C Gorman; Francis G Spinale
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

7.  Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction.

Authors:  Jennifer A Dixon; Robert C Gorman; Robert E Stroud; Shenikqua Bouges; Hamamoto Hirotsugu; Joseph H Gorman; Timothy P Martens; Silviu Itescu; Michael D Schuster; Theodore Plappert; Martin G St John-Sutton; Francis G Spinale
Journal:  Circulation       Date:  2009-09-15       Impact factor: 29.690

8.  Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction.

Authors:  Sara Weis; Satoshi Shintani; Alberto Weber; Rudolf Kirchmair; Malcolm Wood; Adrianna Cravens; Heather McSharry; Atsushi Iwakura; Young-Sup Yoon; Nathan Himes; Deborah Burstein; John Doukas; Richard Soll; Douglas Losordo; David Cheresh
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

9.  Inhibition of the cardiac angiogenic response to exogenous vascular endothelial growth factor.

Authors:  Pierre Voisine; Cesario Bianchi; Marc Ruel; Tamer Malik; Audrey Rosinberg; Jun Feng; Tanveer A Khan; Shu-Hua Xu; Jennifer Sandmeyer; Roger J Laham; Frank W Sellke
Journal:  Surgery       Date:  2004-08       Impact factor: 3.982

10.  Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction.

Authors:  Aernout M Beek; Harald P Kühl; Olga Bondarenko; Jos W R Twisk; Mark B M Hofman; Willem G van Dockum; Cees A Visser; Albert C van Rossum
Journal:  J Am Coll Cardiol       Date:  2003-09-03       Impact factor: 24.094

View more
  5 in total

Review 1.  Thyroid hormones and cardiovascular disease.

Authors:  Avais Jabbar; Alessandro Pingitore; Simon H S Pearce; Azfar Zaman; Giorgio Iervasi; Salman Razvi
Journal:  Nat Rev Cardiol       Date:  2016-11-04       Impact factor: 32.419

2.  Bone marrow-derived multipotent stromal cells promote myocardial fibrosis and reverse remodeling of the left ventricle.

Authors:  Timur Fatkhudinov; Galina Bolshakova; Irina Arutyunyan; Andrey Elchaninov; Andrey Makarov; Evgeniya Kananykhina; Oksana Khokhlova; Arkady Murashev; Valeria Glinkina; Dmitry Goldshtein; Gennady Sukhikh
Journal:  Stem Cells Int       Date:  2015-01-21       Impact factor: 5.443

3.  Anatomical-Molecular Distribution of EphrinA1 in Infarcted Mouse Heart Using MALDI Mass Spectrometry Imaging.

Authors:  Stephan Lefcoski; Kimberly Kew; Shaun Reece; Maria J Torres; Justin Parks; Sky Reece; Lisandra E de Castro Brás; Jitka A I Virag
Journal:  J Am Soc Mass Spectrom       Date:  2018-01-05       Impact factor: 3.109

4.  The aqueous extract of Gentianella acuta improves isoproterenol‑induced myocardial fibrosis via inhibition of the TGF‑β1/Smads signaling pathway.

Authors:  Hong-Xia Yang; Geng-Rui Xu; Chuang Zhang; Jia-Huan Sun; Yue Zhang; Jun-Na Song; Yun-Feng Li; Yu Liu; Ai-Ying Li
Journal:  Int J Mol Med       Date:  2019-11-21       Impact factor: 4.101

5.  Pharmacologic ATF6 activation confers global protection in widespread disease models by reprograming cellular proteostasis.

Authors:  Erik A Blackwood; Khalid Azizi; Donna J Thuerauf; Ryan J Paxman; Lars Plate; Jeffery W Kelly; R Luke Wiseman; Christopher C Glembotski
Journal:  Nat Commun       Date:  2019-01-14       Impact factor: 17.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.